Cole Pinnow's Insider Trades & SAST Disclosures
Cole Pinnow's most recent trade in Cogent Biosciences Inc was a trade of 240,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 23, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Cole Pinnow.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cogent Biosciences Inc | Cole Pinnow | Chief Commercial Officer | 23 Jan 2025 | 240,000 | 240,000 | - | - | Stock Option (Right to Buy) | ||
| Cogent Biosciences Inc | Cole Pinnow | Chief Commercial Officer | 14 Jan 2025 | 43,750 | 45,848 (0%) | 0% | 7.6 | 332,413 | Common Stock | |
| Cogent Biosciences Inc | Cole Pinnow | Chief Commercial Officer | 25 May 2024 | 525,000 | 525,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges